CS
LLY icon

Capital Square’s Eli Lilly LLY Stock Holding History

Capital Square’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61M Sell
4,720
-60
-1% -$61.3K 2.47% 3
2026
Q1 		$4.23M Sell
4,780
-772
-14% -$783K 1.95% 7
2025
Q4 		$5.97M Sell
5,552
-68
-1% -$65K 3.04% 3
2025
Q3 		$4.29M Sell
5,620
-77
-1% -$57.3K 2.19% 5
2025
Q2 		$4.52M Buy
5,697
+508
+10% +$395K 2.41% 4
2025
Q1 		$4.29M Buy
5,189
+115
+2% +$95.7K 2.52% 3
2024
Q4 		$3.99M Buy
5,074
+14
+0.3% +$11.6K 2.26% 4
2024
Q3 		$4.48M Sell
5,060
-192
-4% -$173K 2.72% 3
2024
Q2 		$4.55M Buy
5,252
+326
+7% +$261K 2.96% 3
2024
Q1 		$3.83M Buy
4,926
+131
+3% +$93.2K 2.71% 3
2023
Q4 		$2.8M Buy
4,795
+408
+9% +$238K 3.16% 4
2023
Q3 		$2.66M Sell
4,387
-4
-0.1% -$2.06K 3.59% 3
2023
Q2 		$2.06M Sell
4,391
-48
-1% -$20.1K 1.91% 12
2023
Q1 		$1.64M Sell
4,439
-35
-0.8% -$11.8K 1.51% 17
2022
Q4 		$1.64M Sell
4,474
-33
-0.7% -$11.7K 1.48% 18
2022
Q3 		$1.46M Buy
4,507
+225
+5% +$71.3K 1.32% 21
2022
Q2 		$1.39M Sell
4,282
-9
-0.2% -$2.7K 1.15% 23
2022
Q1 		$1.23M Sell
4,291
-8
-0.2% -$2.06K 0.88% 37
2021
Q4 		$1.12M Buy
4,299
+8
+0.2% +$2.03K 0.77% 41
2021
Q3 		$985K Buy
4,291
+3
+0.1% +$740 0.7% 46
2021
Q2 		$1.02M Sell
4,288
-2
-0% -$402 0.75% 44
2021
Q1 		$791K Buy
4,290
+27
+0.6% +$5.28K 0.59% 57
2020
Q4 		$719K Buy
4,263
+18
+0.4% +$2.69K 0.6% 56
2020
Q3 		$628K Buy
4,245
+67
+2% +$10.4K 0.65% 52
2020
Q2 		$686K Sell
4,178
-217
-5% -$33.3K 0.73% 41
2020
Q1 		$610K Sell
4,395
-213
-5% -$29.3K 0.71% 38
2019
Q4 		$605K Buy
+4,608
New +$534K 0.58% 50

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Square's LLY Position: Q2 2026 in Review

Capital Square reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $61.3K and leaving 4,720 shares worth $5.61M. The position accounts for 2.47% of the portfolio, ranked #3.

Capital Square first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.97M in Q4 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capital Square held 4,720 shares of Eli Lilly worth $5.61M as of Q2 2026.
  • Capital Square sold 60 Eli Lilly shares in Q2 2026, an estimated $61.3K.
  • Eli Lilly made up 2.47% of Capital Square's portfolio in Q2 2026, its #3 holding.
  • Capital Square first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • Capital Square's Eli Lilly position peaked at $5.97M in Q4 2025.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Square's 13F filing for Q2 2026, filed 13 Aug 2026.